1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| Cucurbitacin I | 葫芦素 I | 2222-07-3 |
| Ritlecitinib | 利特昔替尼 | 1792180-81-4 |
| AEBSF hydrochloride | 4-(2-氨乙基)苯磺酰氟盐酸盐 | 30827-99-7 |
| N-Glycolylneuraminic acid | N-羟乙酰神经氨酸 | 1113-83-3 |
| Trimethobenzamide hydrochloride | 盐酸三甲氧苯酰胺 | 554-92-7 |
| CBS1117 | 化合物CBS1117 | 959245-08-0 |
| MBX2329 | 1-(2-(2-乙基苯氧基)乙基)氮杂环庚烷盐酸盐 | 1438272-42-4 |
| Molnupiravir | 莫那比拉韦 | 2492423-29-5 |
| (-)-JNJ-A07 | 化合物 (-)-JNJ-A07 | 2135640-92-3 |
| Neuraminidase-IN-1 | Compound Y-1 | 2379438-80-7 |
| 6-Azathymine | 6-氮杂胸腺嘧啶 | 932-53-6 |
| Zapnometinib | 2-(2-CHLORO-4-IODOPHENYLAMINO)-3,4-DIFLUOROBENZOIC ACID | 303175-44-2 |
| GSK 650394 | 2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 | 890842-28-1 |
| Laninamivir | 拉尼米韦 | 203120-17-6 |
| Gusacitinib | GUSACITINIB | 1425381-60-7 |
| IMD 0354 | N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺 | 978-62-1 |
| Abrocitinib | PF-04965842(阿布罗替尼) | 1622902-68-4 |
| Itacnosertib | N4-([2,2-bipyridin]-3-yl)-N2-(3-methoxy-4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,4-diamine | 1628870-27-8 |
| WHI-P154 | 2-溴-4-(6,7-二甲氧基喹唑啉-4-基氨基)苯酚 | 211555-04-3 |
| MRT67307 | N-[3-[[5-环丙基-2-[[3-(4-吗啉基甲基)苯基]氨基]-4-嘧啶基]氨基]丙基]环丁烷甲酰胺 | 1190378-57-4 |
| BMS345541 hydrochloride | N-(1,8-二甲基咪唑并[1,2-A]喹喔啉-4-基)-1,2-乙二胺盐酸盐 | 547757-23-3 |
| Golidocitinib | AZD4205 | 2091134-68-6 |
| PF-06263276 | PF-06263276 (PF 6263276) | 1421502-62-6 |
| Delgocitinib | 迪高替尼 | 1263774-59-9 |
| BMS-911543 | BMS-911543 | 1271022-90-2 |
| Fedratinib hydrochloride hydrate | TG-101348 | 1374744-69-0 |
| ZM 39923 HCl | 3-[异丙基(苄基)氨基]-1-(2-萘基)-1-丙酮盐酸盐 | 1021868-92-7 |
| Ketotifen-d3 (fumarate) | YNQQEYBLVYAWNX-PCUGBSCUSA-N | 1795138-23-6 |
| ML 120B dihydrochloride(free base) | N-(6-氯-7-甲氧基-9H-吡啶并[3,4-B]吲哚-8-基)-2-甲基-3-吡啶甲酰胺 | 783348-36-7 |
| PS-1145 | PS-1145 | 431898-65-6 |
| Lorpucitinib | 化合物 LORPUCITINIB | 2230282-02-5 |
| Fedratinib | N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | 936091-26-8 |
| Tanzisertib | TANZISERTIB | 899805-25-5 |
| JAK-IN-1 | JAK-IN-1 | 1334673-53-8 |
| CC-90001 | CC90001 | 1403859-14-2 |
| ZM 449829 | 2-萘乙烯基酮 | 4452-06-6 |
| BMS-986202 | BMS-986202 | 1771691-34-9 |
| IQ-1S free acid | 11H-茚并[1,2-b]喹喔啉-11-酮肟 | 23146-22-7 |
| WHI-P258 | WHI-P258 | 21561-09-1 |
| G5-7 | 化合物JAK2 INHIBITOR G5-7 | 939681-36-4 |
| Decernotinib(VX-509) | 迪西替尼 | 944842-54-0 |
| Tyk2-IN-7 | TYK2-IN-7 (COMPOUND 48) | 1609391-90-3 |
| SC99 | SC-99 | 882290-02-0 |
| CEP-33779 | N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 | 1257704-57-6 |
| Cerdulatinib hydrochloride | CERDULATINIB 盐酸盐 | 1369761-01-2 |
| Itacitinib adipate | 1334302-63-4 | 1334302-63-4 |
| NVP-BSK805 | NVP-BSK805 dihydrochloride | 1092499-93-8 |
| BD750 | 2-(2-Benzothiazolyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol | 892686-59-8 |
| JAK3-IN-1 | 1805787-93-2 | 1805787-93-2 |
| J30-8 | J30-8 | 2366255-71-0 |
| Itacitinib | 伊他替尼 | 1334298-90-6 |
| GDC-4379 | 化合物 GDC-4379 | 2252277-73-7 |
| Ruxolitinib phosphate | 鲁索利替尼磷酸盐 | 1092939-17-7 |
| SR-3306 | 化合物SR-3306 | 1128096-91-2 |
| Ilginatinib | 1239358-86-1 | 1239358-86-1 |
| Oclacitinib maleate | PF-03394197 | 1640292-55-2 |
| AS 602801 | 本塔马莫 | 848344-36-5 |
| NVP-BSK805 dihydrochloride | 1942919-79-0 | 1942919-79-0 |
| Brepocitinib P-Tosylate | CS-2860 | 2140301-96-6 |
| D-JNKI-1 | 1445179-97-4 | 1445179-97-4 |
| MPT0B392 | MPT0B392 | 1346169-92-3 |
| Pumecitinib | 2401057-12-1 | |
| (+)-DHMEQ | 287194-41-6 | 287194-41-6 |
| Nrf2-IN-1 | 1-(4-(tert-butyl)benzyl)-3-(4-chlorophenyl)-N-hydroxy-1H-pyrazole-5-carboxamide | 1610022-76-8 |
| KI696 isomer | KI696 isomer | 1799974-69-8 |
| DDO-7263 | 化合物DDO-7263 | 2254004-96-9 |
| Solcitinib | SOLCITINIB | 1206163-45-2 |
| (2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoic acid | LCZ696杂质518-12对照品 | 1639970-62-9 |
| TAK-448 acetate | TAK-448 acetate | 1470374-22-1 |
| Jnk-IN-7 | 3-[[4-(二甲基氨基)-1-氧代-2-丁烯-1-基]氨基]-N-[4-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯基]苯甲酰胺 | 1408064-71-0 |
| Kainic acid | 红藻氨酸, ** | 487-79-6 |
| SB1317 | 14-甲基-20-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,10,12(26),16,21,23-十烯 | 937270-47-8 |
| DB07268 | 2-[[2-[(3-羟基苯基)氨基]-4-嘧啶基]氨基]苯甲酰胺 | 929007-72-7 |
| (R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2- methylpent-2-enoic acid | LCZ696杂质26对照品 | 1012341-48-8 |
| Pyridone 6 | 2-(1,1-二甲基乙基)-9-氟-1,6-二氢-7H-苯并[H]咪唑并[4,5-F]异喹啉-7-酮 | 457081-03-7 |
| VVD-118313 | 2875046-27-6 | |
| (3S,5R)-4-[5-([1,1'-Biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl]-4-oxobutanoic acid | LCZ696杂质506-07对照品 | 2216746-87-9 |
| AEG 3482 | 6-苯基咪唑并[2,1-B]-1,3,4-噻二唑-2-磺酰胺 | 63735-71-7 |
| LY2784544 | LY 2784544 | 1229236-86-5 |
| CDDO-EA | CS-1305 | 932730-51-3 |
| Dimethyl fumarate-d6 | 富马酸二甲酯D6 | 66487-95-4 |
| Upadacitinib | 乌帕替尼 | 1310726-60-3 |
| ML334 | ML334 | 1432500-66-7 |
| KI696 | KI-696 | 1799974-70-1 |
| Anisomycin | 茴香霉素 | 22862-76-6 |
| CDDO-dhTFEA | RTA dh404 | 1191265-33-4 |
| Ivarmacitinib | 化合物SHR0302 | 1445987-21-2 |
| SR15006 | SR 15006 | 2505001-54-5 |
| JANEX-1 | 4-(4'-羟基苯基)氨基-6,7-二甲氧基喹唑啉 | 202475-60-3 |
| Bardoxolone | 2-氰基-3,12-二氧代齐墩果-1,9-二烯-28-酸 | 218600-44-3 |
| Ezetimibe-d4-1 | 依折麦布杂质-d4 | 1093659-89-2 |
| NK-252 | 1414963-82-8 | 1414963-82-8 |
| (2R,4S)-4-([1,1'-Biphenyl]-4-ylmethyl)-4-(4-ethoxy-4- oxobutanamido)-2-methylbutanoic acid | LCZ696杂质522-12对照品 | 149709-49-9 |
| Deucravacitinib | BMS-986165 | 1609392-27-9 |
| Propan-2-yl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4- [4-(propan-2-yloxy)-4-oxobutanamido]butanoate | LCZ696杂质523-12对照品 | 2216755-67-6 |
| CBR-470-2 | 2416095-00-4 | |
| CC-401 | 3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑 | 395104-30-0 |
| Baricitinib | 巴瑞克替尼 | 1187594-09-7 |
| Pyridoxine-d3 (hydrochloride) | Pyridoxine-[D3] HCl (Vitamin B6-[D3]) | 1189921-12-7 |
| 4-Octyl Itaconate | 衣康酸盐 | 3133-16-2 |
联系方式
